Benztropine Mesylate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Home SubjectClassCompaniesIngredientsNames A-Z
Search
Home – Benztropine Mesylate

Benztropine Mesylate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BENZTROPINE MESYLATE DESCRIPTION



Benztropine Mesylate



CLINICAL PHARMACOLOGY




INDICATIONS & USAGE


PRECAUTIONS) due to neuroleptic drugs (e.g., phenothiazines).

BENZTROPINE MESYLATE CONTRAINDICATIONS



WARNINGS





PRECAUTIONS

General







Drug Interactions
WARNINGS).

Pediatric Use
CONTRAINDICATIONS).

BENZTROPINE MESYLATE ADVERSE REACTIONS


CardiovascularTachycardia.
DigestiveParalytic ileus, constipation, vomiting, nausea, dry mouth.


Nervous System
Special SensesBlurred vision, dilated pupils.
UrogenitalUrinary retention, dysuria.
Metabolic/Immune or SkinOccasionally, an allergic reaction, e.g., skin rash, develops. If this cannot be controlled by dosage reduction, the medication should be discontinued.
OtherHeat stroke, hyperthermia, fever.

OVERDOSAGE

Manifestations


Treatment
* A second injection may be given after 2 hours if required. Otherwise treatment is symptomatic and supportive. Induce emesis or perform gastric lavage (contraindicated in precomatose convulsive, or psychotic states). Maintain respiration. A short-acting barbiturate may be used for CNS excitement, but with caution to avoid subsequent depression; supportive care for depression (avoid convulsant stimulants such as picrotoxin, pentylenetetrazole, or bemegride); artificial respiration for severe depression; a local miotic for mydriasis and cyclopegia; ice bags or other cold applications and alcohol sponges for hyperpyrexia, a vasopressor and fluids for circulatory collapse. Darken room for photophobia.

DOSAGE & ADMINISTRATION




Postencephalitic and Idiopathic Parkinsonism









Drug-Induced Extrapyramidal Disorders



HOW SUPPLIED





STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Benztropine Mesylate


Benztropine Mesylate

Benztropine Mesylate

BENZTROPINE MESYLATE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-933(NDC:0603-2434)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BENZTROPINE MESYLATE BENZTROPINE 1 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline

Product Characteristics

Color Size Imprint Code Shape
white 10 mm 2326;V OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-933-10 6 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040742 2012-11-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.
Designed by Tank
Developed by KB.MD